NPPB and heart failure: Furthermore, our CHD patients exhibited a trend toward higher hs-CRP levels, a marker of systemic inflammation, and statistically significantly higher NT-pro-BNP concentrations, a marker of heart failure, which may reflect an increased burden of cardiometabolic dysregulation.